triethylammonium bis(isopropyloxycarbonyloxymethyl)phosphate | 1451187-92-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磷酸及其衍生物
• 英文名称: triethylammonium bis(isopropyloxycarbonyloxymethyl)phosphate
• 英文别名: Bis(propan-2-yloxycarbonyloxymethyl) phosphate;triethylazanium；bis(propan-2-yloxycarbonyloxymethyl) phosphate;triethylazanium
• CAS: 1451187-92-0
• 化学式: C₆H₁₅N*C₁₀H₁₉O₁₀P
• 分子量: 431.42
• InChiKey: MSJFTQLFJNMAIK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.46
• 重原子数：
  28
• 可旋转键数：
  15
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  134
• 氢给体数：
  1
• 氢受体数：
  10

反应信息

• 作为反应物：
  描述：

  triethylammonium bis(isopropyloxycarbonyloxymethyl)phosphate 在 甲酸 、 双(2-氧代-3-恶唑烷基)次磷酰氯 、 N,N-二异丙基乙胺 、 3-硝基-1,2,4-三氮唑 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 3.5h， 生成 [3-[(2R,3R,4S,5R)-5-[bis(propan-2-yloxycarbonyloxymethoxy)phosphoryloxymethyl]-5-(fluoromethyl)-3,4-dihydroxy-3-methyloxolan-2-yl]-2,6-dioxopyrimidin-1-yl]methyl 3-methyl-2-(phenylmethoxycarbonylamino)butanoate
  参考文献：
  名称：

  SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

  摘要：

  本文披露了核苷、核苷酸和核苷酸类似物，其合成方法以及利用一个或多个核苷、核苷酸和核苷酸类似物治疗冠状病毒科病毒、托加病毒科病毒、肝炎病毒科病毒和/或布尼亚病毒科病毒感染的方法。

  公开号：

  US20150366888A1
• 作为产物：
  描述：

  氯甲基碳酸异丙酯 、 三乙胺 在 磷酸三甲酯 、 sodium iodide 作用下， 以 丙酮 、 水 为溶剂， 生成 triethylammonium bis(isopropyloxycarbonyloxymethyl)phosphate
  参考文献：
  名称：

  [EN] DIDEHYDRO-3'-DEOXY-4'-ETHYNYLTHYMIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
  [FR] DIDÉHYDRO-3'-DÉSOXY-4'-ÉTHYNYLTHYMIDINES, COMPOSÉS APPARENTÉS ET LEUR UTILISATION DANS LE TRAITEMENT D'AFFECTIONS MÉDICALES

  摘要：

  The invention provides substituted 2',3'-didehydro-3'-deoxy-4'-ethynylthymidines and related compounds, pharmaceutical compositions, their use for inhibiting LINE1 reverse transcriptase activity, their use for inhibiting HERV-K reverse transcriptase activity, and their use in the treatment of medical disorders, such as cancer.

  公开号：

  WO2023205786A1

文献信息

• [EN] SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF<br/>[FR] NUCLÉOSIDES, NUCLÉOTIDES SUBSTITUÉS ET LEURS ANALOGUES
  申请人：ALIOS BIOPHARMA INC

  公开号：WO2014209979A1

  公开（公告）日：2014-12-31

  Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a norovirus, with a nucleoside, a nucleotide and an analog thereof.

  本文揭示了核苷、核苷酸及其类似物，包括一个或多个核苷、核苷酸及其类似物的药物组合物，以及它们的合成方法。本文还揭示了利用核苷、核苷酸及其类似物改善和/或治疗疾病和/或病况的方法，包括使用核苷、核苷酸和其类似物治疗诺如病毒感染的方法。
• [EN] BI- AND MONOCYCLIC NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E<br/>[FR] ANALOGUES NUCLÉOSIDIQUES BICYCLIQUES ET MONOCYCLIQUES POUR LE TRAITEMENT DE L'HÉPATITE E
  申请人：JANSSEN SCIENCES IRELAND UNLIMITED CO

  公开号：WO2021209419A1

  公开（公告）日：2021-10-21

  The present disclosure is directed toward bi- and monocyclic nucleoside analogs, and compositions comprising these compounds for use in the treatment of hepatitis E infections.

  本公开涉及双环和单环核苷类似物，以及包含这些化合物的组合物，用于治疗乙型肝炎感染。
• [EN] SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF<br/>[FR] NUCLÉOSIDES, NUCLÉOTIDES SUBSTITUÉS ET ANALOGUES DE CEUX-CI
  申请人：ALIOS BIOPHARMA INC

  公开号：WO2013142525A1

  公开（公告）日：2013-09-26

  Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof.

  本文披露了核苷、核苷酸及其类似物，包括一个或多个核苷、核苷酸及其类似物的制药组合物，以及其合成方法。本文还披露了使用核苷、核苷酸和其类似物改善和/或治疗疾病和/或病况的方法，包括从副黏病毒和/或正黏病毒感染中治疗。
• [EN] SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF<br/>[FR] NUCLÉOSIDES SUBSTITUÉS, NUCLÉOTIDES SUBSTITUÉS ET ANALOGUES DE CEUX-CI
  申请人：ALIOS BIOPHARMA INC

  公开号：WO2013096679A1

  公开（公告）日：2013-06-27

  Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a paramyxovirus and/or an orthomyxovirus, with a nucleoside, a nucleotide and an analog thereof.

  本文披露了核苷、核苷酸及其类似物，包括一个或多个核苷、核苷酸及其类似物的制药组合物，以及其合成方法。本文还披露了使用核苷、核苷酸和其类似物来改善和/或治疗疾病和/或病况的方法，包括来自副黏病毒和/或正黏病毒的感染。
• AMP-ACTIVATED PROTEIN KINASE ACTIVATING COMPOUNDS AND USES THEREOF
  申请人：Skylark Bioscience LLC

  公开号：US20220133765A1

  公开（公告）日：2022-05-05

  The present invention relates to pharmaceutical compounds, compositions and methods, especially as they relate to the treatment and/or prevention of conditions such as muscle disorders such as polymyositis, dermatomyositis, muscular dystrophy, myasthenia gravis, amyotrophic lateral sclerosis, rhabdomyolysis, and cardiomyopathy, brain disorders including Alzheimer's, stroke, cerebral atrophy, traumatic brain injury, and dementia, aging, diabetes, and cancer, using compounds of Formula (I): as described herein, including pharmaceutically acceptable salts thereof and pharmaceutical compositions comprising these compounds.

  本发明涉及制药化合物、组合物和方法，特别是涉及治疗和/或预防肌肉疾病，如多发性肌炎、皮肌炎、肌肉萎缩症、重症肌无力、肌纤维溶解症和心肌病，脑部疾病，包括阿尔茨海默病、中风、脑萎缩、创伤性脑损伤和痴呆症，衰老、糖尿病和癌症，使用如下式(I)所述的化合物，包括其药学上可接受的盐和含有这些化合物的制药组合物。